# Cagrilintide plus semaglutide: weight loss and safety

Source: https://pepvault.app/research/cagrilintide-enebo-2021

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Cagrilintide](https://pepvault.app/research#cagrilintide)

Randomized trial · people

# Cagrilintide with semaglutide: 17.1% weight loss at 2.4 mg, week 20

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In this early 20-week trial, adding cagrilintide to semaglutide 2.4 mg brought more weight loss than semaglutide with placebo, and the share of people with side effects was similar between groups.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 96
- **Published:** 2021
- **Journal:** Lancet

## What they tested

The team tested whether adding weekly cagrilintide shots to semaglutide 2.4 mg was safe and tolerable, and how the two drugs behaved in the body together.

## How the study was done

A randomized, double-blind, placebo-controlled phase 1b trial at one US center in 96 otherwise healthy adults aged 18-55 with a BMI of 27.0-39.9 kg/m2. In six cohorts, people got weekly cagrilintide (0.16 to 4.5 mg) or placebo (a dummy shot), always with weekly semaglutide 2.4 mg, with doses raised over 16 weeks, then 4 weeks at the target dose and 5 weeks of follow-up, with no diet or exercise program.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking cagrilintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

Side effects were common in both groups: 69 of 71 people (97%) on cagrilintide and 23 of 24 (96%) on placebo had at least one, mostly mild to moderate, and 207 (37%) of the 566 events were gut-related. At week 20, weight fell 15.7% in the 1.2 mg arm and 17.1% in the 2.4 mg arm vs 9.8% in pooled placebo, an estimated difference of -6.0% and -7.4%; the 4.5 mg arm lost 15.4% vs 8.0% on its matched placebo (difference -7.4%). Cagrilintide levels rose in line with dose, its half-life (time for blood levels to halve) was 159-195 h, and it did not change semaglutide levels or clearance. Blood sugar measures improved in all groups regardless of cagrilintide dose.

## What it doesn’t show

This was a small, short early-phase trial in otherwise healthy adults at a single center, and weight change was an exploratory endpoint, not the main one. It was funded by Novo Nordisk.

## The paper

Enebo et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial. Lancet. 2021.

- [PubMed (PMID 33894838)](https://pubmed.ncbi.nlm.nih.gov/33894838/)
- [The paper (DOI 10.1016/S0140-6736(21)00845-X)](https://doi.org/10.1016/S0140-6736%2821%2900845-X)
- [ClinicalTrials.gov (NCT03600480)](https://clinicaltrials.gov/study/NCT03600480)

## The compounds

- [Cagrilintide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/cagrilintide)
- [Semaglutide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/semaglutide)
- [Cagrilintide dose guide](https://pepvault.app/lab/dosage/cagrilintide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

## With this study

### Cagrilintide

- [Cagrilintide: the full reference](https://pepvault.app/peptides/cagrilintide)
- [Cagrilintide dose guide](https://pepvault.app/lab/dosage/cagrilintide)

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Mixing charts

- [Cagrilintide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/cagrilintide-5mg)
- [Cagrilintide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/cagrilintide-10mg)
- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)

### Studies

- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [All 2 studies](https://pepvault.app/research#cagrilintide)
- [Semaglutide (oral): smaller HbA1c drop than orforglipron in ACHIEVE-3](https://pepvault.app/research/semaglutide-achieve-3-2026)
- [Semaglutide (oral) did not slow early Alzheimer's in evoke trials](https://pepvault.app/research/semaglutide-oral-evoke-and-evoke-2026)
- [All 20 studies](https://pepvault.app/research#semaglutide)

### Compared with

- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Retatrutide vs Cagrilintide](https://pepvault.app/peptides/compare/retatrutide-vs-cagrilintide)
- [Tirzepatide vs Cagrilintide](https://pepvault.app/peptides/compare/tirzepatide-vs-cagrilintide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Half-life](https://pepvault.app/glossary/half-life)
- [Placebo](https://pepvault.app/glossary/placebo)

## More studies on Cagrilintide

- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026) Randomized trial · people · 2026
- [Every study on Cagrilintide](https://pepvault.app/research#cagrilintide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking cagrilintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking cagrilintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Cagrilintide

- [Cagrilintide: the full reference](https://pepvault.app/peptides/cagrilintide)
- [Cagrilintide dose guide](https://pepvault.app/lab/dosage/cagrilintide)

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Mixing charts

- [Cagrilintide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/cagrilintide-5mg)
- [Cagrilintide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/cagrilintide-10mg)
- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)

### Studies

- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [All 2 studies](https://pepvault.app/research#cagrilintide)
- [Semaglutide (oral): smaller HbA1c drop than orforglipron in ACHIEVE-3](https://pepvault.app/research/semaglutide-achieve-3-2026)
- [Semaglutide (oral) did not slow early Alzheimer's in evoke trials](https://pepvault.app/research/semaglutide-oral-evoke-and-evoke-2026)
- [All 20 studies](https://pepvault.app/research#semaglutide)

### Compared with

- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Retatrutide vs Cagrilintide](https://pepvault.app/peptides/compare/retatrutide-vs-cagrilintide)
- [Tirzepatide vs Cagrilintide](https://pepvault.app/peptides/compare/tirzepatide-vs-cagrilintide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Half-life](https://pepvault.app/glossary/half-life)
- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Taking cagrilintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Cagrilintide](https://pepvault.app/research#cagrilintide)

## The library

- [Cagrilintide](https://pepvault.app/peptides/cagrilintide)
- [Cagrilintide dose guide](https://pepvault.app/lab/dosage/cagrilintide)
- [Semaglutide](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it. Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda, Victoza and Trulicity are trademarks of their respective owners; PepVault is independent and not affiliated with or endorsed by any manufacturer.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
